Rengui Zhou Lei Song Wenwen Zhang Lin Shao Xi Li Xiangyong Li
10.2147/OTT.S298655
Onco Targets Ther
2021 Apr 28;14:2847-2851.
egfr c797s egfr t790m egfr tki nsclc anlotinib osimertinib
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/33958875/
Case Reports
PMC8093742
33958875
Combination of Osimertinib and Anlotinib May Overcome the Resistance Mediated by in cis EGFR T790M-C797S in NSCLC: A Case Report
2021